The global pharmaceutical market research has been done by many
companies and almost all of the market reports indicate a significant growth
of of pharma market in 2010. The forecasting indicates pharmaceutical market
growth of about 4 - 6% in 2010.
Pharmaceutical Industry Trends- Global Scenario
If present
industry overview is taken into consideration then the global pharmaceutical
market in 2010 is projected to grow 4 - 6% exceeding $825 billion. The
global pharmaceutical market sales is expected to grow at a 4 - 7% compound
annual growth rate (CAGR) through 2013. This industry growth is driven by
stronger near-term growth in the US market and is based on the global
macroeconomy, the changing combination of innovative and mature products
apart from the rising influence of healthcare access and funding on market
demand. Global pharmaceutical market value is expected to expand to $975+
billion by 2013. Different regions of the world will influence the
pharmaceutical industry trends in different ways.
Asia Pacific Pharmaceutical Market
The pharma market world over
will experience significant shifts. Asia-Pacific region will emerge as the
fastest growing pharmaceutical market over the recent past. The reason for
this positive shift can be attributed to the low costs and favorable
regulatory environment. This region has experienced important developments
regarding contract manufacturing, especially in generics and APIs. Increased
R&D activities in the region has helped Asia-Pacific pharmaceutical
industry to achieve an estimated market size of around US$ 187 Billion in
2009. Here, the pharmaceutical industry is expected to grow at a CAGR of
around 12.6% during 2010-2012. It can, in fact, become the global API
production hub in next few years.
pharmaceutical sales are growing at a fast rate in India, China, Malaysia,
South Korea and Indonesia due to the rising disposable income, several
health insurance schemes (that ensures the sales of branded drugs), and
intense competition among
top
pharmaceutical companies in the region (that has boosted the
availability of low cost drugs). China’s pharmaceutical market will
continue to grow at a 20+ % annually, and will contribute 21% of overall
global growth through 2013.
India - 3rd
Largest Producer of Pharmaceuticals Across the World- is already a US$
8.2 Billion pharmaceutical market. The Indian
pharmaceutical industry is further
expected to grow by 10% in the year 2010.
Middle East Pharmaceutical Market
The Middle East combined with
the African Pharmaceutical market is projected to grow at a CAGR of around
11% during 2010-2012. The development of infrastructure and rapidly changing
regulations in this region are being seen as the cause of its growth. Also
there is a high prevalence of diseases and huge population base that
increases the overall pharmaceutical sales in this part of the world.
Presently South Africa, Saudi Arabia and Israel dominate the region's
pharmaceutical industry due to their better infrastructure and regulatory
environment. However, The Middle East pharma market depends on imported
pharmaceutical drugs and therapeutics.
The governments of countries in this region are taking measures to raise
their domestic production through heavy investments in the pharmaceutical
industry. How far they are successful in the attempt of becoming
considerable pharma production center remains to be seen.
Pharmaceutical Drugs Trends
Anti-Diabetic
Drugs and those for cardiovascular diseases are expected to see the
fastest growth in 2011. Cardiovascular patients will increase to 251 million
in 2010, with the greatest rate of growth forecast for the US market. This
is due to the changes in demographics and lifestyle that will boost the
cardiovascular sales. However, the growth rates will be limited by continued
patent expiries for major products and due to the lack of of novel
therapies. The
anti-hypertensives
drugs will dominate the global cardiovascular market with a market
share of nearly 50%.
Injection